Welcome to our dedicated page for Molina Hlthcare SEC filings (Ticker: MOH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Decoding Medicaid capitation math, state contract amendments, and medical-loss ratio tables buried in Molina Healthcare’s SEC reports can feel overwhelming. Each new 8-K about a California contract renewal or dual-eligible pilot shifts the company’s outlook, yet the details are scattered across hundreds of pages. That’s why our platform brings Molina Healthcare SEC filings explained simply—turning legal language into clear insights you can act on.
You’ll find every document, from the Molina Healthcare annual report 10-K simplified to the most recent Molina Healthcare quarterly earnings report 10-Q filing, delivered the moment EDGAR releases them. Stock Titan’s AI reads each paragraph, flags shifts in MLR guidance, highlights risk-adjustment accruals, and generates concise takeaways. Need transaction alerts? Follow Molina Healthcare insider trading Form 4 transactions and get Molina Healthcare Form 4 insider transactions real-time—essential for spotting executive sentiment before earnings. Our coverage also includes the Molina Healthcare proxy statement executive compensation for pay-for-quality metrics and the Molina Healthcare 8-K material events explained so you never miss contract wins, provider disputes, or rating agency updates.
Whether you’re comparing segment margins, tracking reserve developments, or simply understanding Molina Healthcare SEC documents with AI, the platform streamlines every step: real-time filing alerts, AI-powered summaries, expert context, and historical search. Use the Molina Healthcare earnings report filing analysis to monitor membership trends, or dive into Molina Healthcare executive stock transactions Form 4 for compliance checks. Complex healthcare disclosures become clear, letting analysts, portfolio managers, and corporate researchers focus on decisions—not document hunting.
T. Rowe Price Associates reported a beneficial ownership stake in Molina Healthcare Inc. totaling 2,207,124 shares, equal to 4.1% of the outstanding common stock. The filing shows the firm has sole voting power over 2,124,376 shares and sole dispositive power over 2,206,422 shares, with no shared voting or dispositive power.
The filing is submitted on Schedule 13G and classifies the filer as an investment adviser. The filer certifies the shares were acquired and are held in the ordinary course of business and states the position was not taken to change or influence control of the issuer, and the filer disclaims beneficial ownership in one section.
Capital Research Global Investors (CRGI) discloses beneficial ownership of 2,166,093 shares of Molina Healthcare common stock, representing 4.0% of 54,200,000 shares believed outstanding. CRGI reports sole voting power over 2,161,524 shares and sole dispositive power over 2,166,093 shares, and identifies itself as an investment adviser organized in Delaware filing under Rule 13d-1(b).
The filing states the position is held in the ordinary course of business and was not acquired to change or influence control of the issuer. Because the stake is under 5%, it is reported on Schedule 13G/A as a passive institutional holding, which signals notable institutional interest without indicating an active control campaign.
Molina Healthcare amended its existing credit facility to add a new Delayed Draw A-2 commitment of $500 million, creating a Term Loan A-2 that matures on August 12, 2027. The new tranche carries an applicable margin of 0.50% for base rate loans and 1.50% for SOFR-based loans and is substantially similar in other terms to the prior credit agreement.
The company states it will use the Term Loan A-2 proceeds to partially fund its previously authorized stock repurchase program as a temporary measure because of the timing of subsidiary dividends to the parent later this year. The amendment and related agreement are included as Exhibit 10.1, with certain schedules omitted from the public filing but available to the SEC upon request. This amendment creates a direct financial obligation under the Amended Credit Agreement.
Ronna Romney, a director of Molina Healthcare (MOH), filed a Form 4 reporting a sale of 700 shares of Molina Healthcare common stock on 08/06/2025 at a volume-weighted average selling price of $153.74 with individual sale prices reported in the range $153.43 to $154.32. The filing shows 17,131 shares are beneficially owned indirectly by the Ronna Romney Revocable Trust. The Form was filed by one reporting person and executed on behalf of Ms. Romney by Jeff D. Barlow under power of attorney on 08/08/2025.
The filing includes an explanatory note that the reported price is the VWAP for sales on the transaction date and offers to provide detailed per-price quantities to Commission staff on request. No derivative transactions are reported and the Form does not state a reason for the sale or explicitly indicate whether the sale was part of a Rule 10b5-1 plan.
Molina Healthcare, Inc. filed a Form 8-K on July 7, 2025 to furnish Item 2.02 information. The company has released a press release (Exhibit 99.1) containing preliminary, unaudited financial results for the second quarter of 2025 and an update to its full-year 2025 adjusted earnings-per-share guidance. No numerical data or qualitative detail is included in the 8-K itself; investors must review the attached press release for specifics. The disclosure is being furnished—not filed—so it is not subject to Section 18 liability or automatically incorporated into other SEC filings. Apart from customary exhibit listings (Exhibit 104 Inline XBRL cover page), the filing reports no other material events, transactions, or changes.
FAQ
What is the current stock price of Molina Hlthcare (MOH)?
What is the market cap of Molina Hlthcare (MOH)?
